This article is a correction to:
IL36G is associated with cutaneous antiviral competence in psoriasis
You-Wang Lu1,2†Yong-Jun Chen3†Nian Shi3Lu-Hui Yang1Hong-Mei Wang1
Rong-Jing Dong1,2,3*
Yi-Qun Kuang4,5*
Yu-Ye Li1*- 1Department of Dermatology and Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China
- 2Hubei Provincial Key Laboratory of Occurrence and Intervention of Kidney Diseases, Medical College, Hubei Polytechnic University, Huangshi, China
- 3Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, China
- 4NHC Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, China
- 5Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming, China
A corrigendum on
IL36G is associated with cutaneous antiviral competence in psoriasis
by Lu Y-W, Chen Y-J, Shi N, Yang L-H, Wang H-M, Dong R-J, Kuang Y-Q and Li Y-Y (2022). . 13:971071. doi: 10.3389/fimmu.2022.971071
In the published article, there was an error in the author list. You-Wang Lu and Yong-Jun Chen contributed equally to this work and share first authorship. The corrected author list appears below.
You-Wang Lu 1,2†, Yong-Jun Chen 3†, Nian Shi 3, Lu-Hui Yang 1, Hong-Mei Wang 1, Rong-Jing Dong 1,2,3*, Yi-Qun Kuang 4,5*, and Yu-Ye Li 1*
†These authors have contributed equally to this work and share first authorship
In the published article, there is an error in the title. Instead of “L36G is associated with cutaneous antiviral competence in psoriasis”, it should be “IL36G is associated with cutaneous antiviral competence in psoriasis”.
The authors state that these errors do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: psoriasis, antiviral protein (AVP), IL36G, keratinocyte, treatment
Citation: Lu Y-W, Chen Y-J, Shi N, Yang L-H, Wang H-M, Dong R-J, Kuang Y-Q and Li Y-Y (2022) Corrigendum: IL36G is associated with cutaneous antiviral competence in psoriasis. Front. Immunol. 13:1043240. doi: 10.3389/fimmu.2022.1043240
Received: 13 September 2022; Accepted: 05 October 2022;
Published: 17 October 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Lu, Chen, Shi, Yang, Wang, Dong, Kuang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rong-Jing Dong, dongrongjing@hbpu.edu.cn; Yi-Qun Kuang, yq610433@hotmail.com; Yu-Ye Li, yyeli2000@126.com
†These authors have contributed equally to this work and share first authorship